[Federal Register Volume 89, Number 175 (Tuesday, September 10, 2024)]
[Notices]
[Pages 73446-73447]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20417]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1416]


Certain Hydrodermabrasion Systems and Components Thereof; Notice 
of Institution of Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that a complaint was filed with the 
U.S. International Trade Commission on August 6, 2024, under section 
337 of the Tariff Act of 1930, as amended, on behalf of HydraFacial LLC 
f/k/a Edge Systems LLC of Long Beach, California. A supplement was 
filed on August 16, 2024. The complaint, as supplemented, alleges 
violations of section 337 based upon the importation into the United 
States, the sale for importation, and the sale within the United States 
after importation of certain hydrodermabrasion systems and components 
thereof by reason of the infringement of certain claims of U.S. Patent 
No. 11,865,287 (``the '287 patent'') and U.S. Patent No. 9,550,052 
(``the '052 patent''). The complaint further alleges that an industry 
in the United States exists as required by the applicable Federal 
Statute. The complainant requests that the Commission institute an 
investigation and, after the investigation, issue a limited exclusion 
order and a cease and desist order.

ADDRESSES: The complaint, except for any confidential information 
contained therein, may be viewed on the Commission's electronic docket 
(EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email 
[email protected]. Hearing impaired individuals are advised that 
information on this matter can be obtained by contacting the 
Commission's TDD terminal on (202) 205-1810. Persons with mobility 
impairments who will need special assistance in gaining access to the 
Commission should contact the Office of the Secretary at (202) 205-
2000. General information concerning the Commission may also be 
obtained by accessing its internet server at https://www.usitc.gov.

FOR FURTHER INFORMATION CONTACT: Susan Orndoff, The Office of Docket 
Services, U.S. International Trade Commission, telephone (202) 205-2560 
or (202) 205-1802.

SUPPLEMENTARY INFORMATION: 
    Authority: The authority for institution of this investigation is 
contained in section 337 of the Tariff Act of 1930, as amended, 19 
U.S.C. 1337, and in section 210.10 of the Commission's Rules of 
Practice and Procedure, 19 CFR 210.10 (2024).
    Scope of Investigation: Having considered the complaint, the U.S. 
International Trade Commission, on September 5, 2024, ordered that--
    (1) Pursuant to subsection (b) of section 337 of the Tariff Act of 
1930, as amended, an investigation be instituted to determine whether 
there is a violation of subsection (a)(1)(B) of section 337 in the 
importation into the United States, the sale for importation, or the 
sale within the United States after importation of certain products 
identified in paragraph (2) by reason of infringement of one or more of 
claims 1-12, 14-20, 22-26, 28-37, and 39-45 of the '287 patent and 
claims 1-8 and 11-16 of the '052 patent, and whether an industry in the 
United States exists as required by subsection (a)(2) of section 337;
    (2) Pursuant to section 210.10(b)(1) of the Commission's Rules of 
Practice and Procedure, 19 CFR 210.10(b)(1), the plain language 
description of the accused products or category of accused products, 
which defines the scope of the investigation, is ``systems and 
subassemblies for skin treatment through mechanical and/or fluid-based 
abrasion or exfoliation'';
    (3) For the purpose of the investigation so instituted, the 
following are hereby named as parties upon which this notice of 
investigation shall be served:
    (a) The complainant is: HydraFacial LLC f/k/a Edge Systems LLC, 
2165 E. Spring St., Long Beach, California 90806
    (b) The respondents are the following entities alleged to be in 
violation of section 337, and are the parties upon which the complaint 
is to be served:

Sinclair Pharma U.S. Inc., 18 Technology Drive, Suite 134, Irvine, CA 
92618
Sinclair Pharma Limited, 1st Floor, Whitfield Court, 30-32 Whitfield 
Street, London W1T 2RQ, United Kingdom
Huadong Medicine Co., Ltd., No. 866 Moganshan Road, Hangzhou, Zhejiang, 
China 310011
EMA Aesthetics, Ltd., 2nd Floor, Palmerston House, Fenian Street, 
Dublin D02WD37, Ireland
Aesthetics Management Partners, 9109 Macon Road, Cordova, TN 38016
Advanced Aesthetics Services LLC, 401 SW 9th Street, Apartment #3, 
Miami, FL 33130
H.R. Meditech, 556-44 Gajwa-dong, Seo-gu, Incheon, Republic of Korea 
22827, and


[[Page 73447]]


    (4) For the investigation so instituted, the Chief Administrative 
Law Judge, U.S. International Trade Commission, shall designate the 
presiding Administrative Law Judge.
    The Office of Unfair Import Investigations will not participate as 
a party in this investigation.
    Responses to the complaint and the notice of investigation must be 
submitted by the named respondents in accordance with section 210.13 of 
the Commission's Rules of Practice and Procedure, 19 CFR 210.13. 
Pursuant to 19 CFR 201.16(e) and 210.13(a), as amended in 85 FR 15798 
(March 19, 2020), such responses will be considered by the Commission 
if received not later than 20 days after the date of service by the 
complainant of the complaint and the notice of investigation. 
Extensions of time for submitting responses to the complaint and the 
notice of investigation will not be granted unless good cause therefor 
is shown.
    Failure of a/respondent to file a timely response to each 
allegation in the complaint and in this notice may be deemed to 
constitute a waiver of the right to appear and contest the allegations 
of the complaint and this notice, and to authorize the administrative 
law judge and the Commission, without further notice to the respondent, 
to find the facts to be as alleged in the complaint and this notice and 
to enter an initial determination and a final determination containing 
such findings, and may result in the issuance of an exclusion order or 
a cease and desist order or both directed against the respondent.

    By order of the Commission.

    Issued: September 5, 2024.
Sharon Bellamy,
Supervisory Hearings and Information Officer.
[FR Doc. 2024-20417 Filed 9-9-24; 8:45 am]
BILLING CODE 7020-02-P